MD saiful Islam Khan
- The US Food and Drug Administration approved on Thursday on Alnylam Pharmaceuticals (Nasdak:now(App for the neurotic or genetic nephrosis is an ATTR-CM to put signs of RNAI AMVUTTRA (Vutrisiraan) treatment.
- Treatment has already been approved for theatromistic disease of disease of hematocardotial mixture by blood-pn.
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1770603419/image_1770603419.jpg?io=getty-c-w750
Source link